Replies to post #145786 on Biotech Values

[mcbio]

Memory Pharma: nothing came out of there for Roche. The ph2 trial finished earlier this year:

clinicaltrials.gov/ct2/show/NCT00884507?term=Mem3454&rank=4

It is no longer listed on Roche's Neuroscience pipeline:

www.roche.com/creating_value/roche_pharma_pipeline.htm

Yeah I did some Googling after my post and came to that conclusion as well. Presumably no efficacy signal in that Phase 2. Hopefully just an issue with the Memory drug itself, or perhaps trial design, and not with the alpha-7 target itself.